---
title: "SGS SA targets 5%-7% sales growth in 2025 with focus on acquisitions and profitability"
date: "2025-02-11 18:45:30"
summary: "Earnings Call Insights: SGS SA (OTCPK:SGSOF) Q4 2024 Management View CEO Geraldine Picaud highlighted excellent results for 2024, with net sales reaching CHF6.8 billion and adjusted operating income of CHF1,040 million. The company achieved a record free cash flow of CHF748 million and executed CHF100 million in cost efficiencies. Picaud..."
categories:
  - "seekalpha"
lang:
  - "en"
translations:
  - "en"
tags:
  - "seekalpha"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

Earnings Call Insights: SGS SA ([OTCPK:SGSOF](https://seekingalpha.com/symbol/SGSOF "SGS SA")) Q4 2024

### Management View

* CEO Geraldine Picaud highlighted excellent results for 2024, with net sales reaching CHF6.8 billion and adjusted operating income of CHF1,040 million. The company achieved a record free cash flow of CHF748 million and executed CHF100 million in cost efficiencies. Picaud also emphasized the success of 14 bolt-on acquisitions, which strengthened the portfolio and added complementary expertise.
* Picaud announced strong growth across key segments, including double-digit growth in sustainability and digital trust services. Key drivers included PFAS testing in North America and increased demand for cybersecurity services fueled by AI advancements. She also noted the launch of a new biosimilars testing facility near Boston.
* CFO Marta Vlatchkova reported a 15.3% operating margin on sales, with organic growth contributing CHF494 million. Vlatchkova emphasized the strong financial discipline, including maintaining leverage at 1.8 times and generating a 24% return on invested capital.

### Outlook

* CEO Picaud projected sales growth of 5%-7% for 2025, with bolt-on acquisitions expected to contribute an additional 1%-2%. She also forecasted a profitability improvement of at least 30 basis points, despite potential foreign exchange headwinds.
* Picaud underscored the company’s commitment to Strategy 27, targeting growth through investments in innovation, acquisitions, and sustainability-focused initiatives.

### Financial Results

* SGS reported net sales of CHF6.8 billion, supported by 7.5% organic growth. Adjusted operating income reached CHF1,040 million, translating to a 15.3% margin, 60 basis points higher than 2023.
* Free cash flow reached a record CHF748 million, up 24% year-over-year, driven by improved net working capital and disciplined CapEx spending.
* Regional highlights included 17% organic growth in Latin America and a strong performance in Asia-Pacific, where Connectivity & Products achieved double-digit growth.
* Health & Nutrition saw a recovery in H2, particularly in biosafety and bioanalysis testing, driving strong margin improvements.

### Q&A

* Annelies Vermeulen, Morgan Stanley: Asked about risks to growth from U.S. deregulation under the incoming administration. CEO Picaud stated that environmental services like PFAS testing remain in high demand, with no expected slowdown. She also highlighted opportunities from U.S. AI investments and Europe’s regulatory standards.
* Will Kirkness, Bernstein: Inquired about margin guidance and organic growth targets. Picaud cited potential macroeconomic and political risks as reasons for conservative guidance but emphasized that organic growth targets are achievable without large-scale M&A.
* Himanshu Agarwal, Bank of America: Questioned the sustainability of cash flow improvements and regulatory impacts. CFO Vlatchkova explained the alignment of incentives to maintain focus on working capital and CapEx discipline. Picaud reiterated robust consumer demand for sustainability services.
* Neil Tyler, Redburn Atlantic: Sought clarification on margin drivers in Health & Nutrition and Natural Resources. Picaud credited operating leverage in labs and strong demand for battery metals testing as key contributors.

### Sentiment Analysis

* Analysts expressed cautious optimism, focusing on sustainability growth drivers, M&A strategy, and margin improvements. Skepticism was evident regarding potential headwinds from macroeconomic and regulatory changes.
* Management maintained a confident tone, emphasizing resilience and strong execution. Phrases like “we are fully on track” and “we see a lot of growth potential” were recurrent.
* Compared to prepared remarks, management was more defensive during the Q&A, particularly on questions about M&A risks and regulatory impacts.

### Quarter-over-Quarter Comparison

* No previous quarter comparison available.
* Analysts focused on the execution of Strategy 27 and margin sustainability.
* Management confidence in achieving 2025 targets was evident, citing strong financial discipline and growth momentum.

### Risks and Concerns

* Macroeconomic and political uncertainties, including foreign exchange volatility, were identified as potential headwinds.
* Analysts raised concerns about sustainability-related deregulation and its medium-term impact on growth.
* Management emphasized mitigation strategies, including focusing on high-growth segments and maintaining financial flexibility through disciplined cost management.

### Final Takeaway

SGS SA delivered strong Q4 2024 results, driven by 7.5% organic growth and record free cash flow. The company emphasized its commitment to achieving Strategy 27 targets, including 5%-7% sales growth in 2025, supported by bolt-on acquisitions and a focus on high-margin segments. While analysts raised questions about macroeconomic risks and regulatory challenges, management remained confident in its ability to capitalize on growth opportunities, particularly in sustainability and digital trust services.

[Read the full Earnings Call Transcript](https://seekingalpha.com/symbol/SGSOF/earnings/transcripts)

[seekalpha](https://seekingalpha.com/news/4406182-sgs-sa-targets-5-percentminus-7-percent-sales-growth-in-2025-with-focus-on-acquisitions-and)
